HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.
Gong W, Wang L, Schubert ML, Kleist C, Neuber B, Wang S, Yang M, Hückelhoven-Krauss A, Wu D, Schmitt A, Müller-Tidow C, Shiku H, Schmitt M, Sellner L.
Gong W, et al. Among authors: schmitt m, schmitt a.
Biomedicines. 2022 Feb 3;10(2):373. doi: 10.3390/biomedicines10020373.
Biomedicines. 2022.
PMID: 35203582
Free PMC article.